These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31918780)

  • 1. Large-scale Lassa fever outbreaks in Nigeria: quantifying the association between disease reproduction number and local rainfall.
    Zhao S; Musa SS; Fu H; He D; Qin J
    Epidemiol Infect; 2020 Jan; 148():e4. PubMed ID: 31918780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling seasonality of Lassa fever incidences and vector dynamics in Nigeria.
    McKendrick JQ; Tennant WSD; Tildesley MJ
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011543. PubMed ID: 37956170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the dynamics of Lassa fever transmission with differential infectivity: Modeling analysis and control strategies.
    Musa SS; Yusuf A; Bakare EA; Abdullahi ZU; Adamu L; Mustapha UT; He D
    Math Biosci Eng; 2022 Sep; 19(12):13114-13136. PubMed ID: 36654038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk maps of Lassa fever in West Africa.
    Fichet-Calvet E; Rogers DJ
    PLoS Negl Trop Dis; 2009; 3(3):e388. PubMed ID: 19255625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the seasonal drivers of transmission for Lassa fever in Nigeria.
    Akhmetzhanov AR; Asai Y; Nishiura H
    Philos Trans R Soc Lond B Biol Sci; 2019 Jun; 374(1775):20180268. PubMed ID: 31056054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic modelling of the large-scale Lassa fever epidemics in Nigeria from 2016 to 2019.
    Musa SS; Zhao S; Gao D; Lin Q; Chowell G; He D
    J Theor Biol; 2020 May; 493():110209. PubMed ID: 32097608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive genetic diversification of Lassa virus associated with the epidemic split of north-central Nigerian and non-Nigerian lineages.
    Li Y; Tian H
    Virology; 2020 Jun; 545():10-15. PubMed ID: 32174454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017-2021: an emerging urban trend.
    Cadmus S; Taiwo OJ; Akinseye V; Cadmus E; Famokun G; Fagbemi S; Ansumana R; Omoluabi A; Ayinmode A; Oluwayelu D; Odemuyiwa S; Tomori O
    Sci Rep; 2023 Nov; 13(1):20855. PubMed ID: 38012226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Musa SS; Zhao S; Abdullahi ZU; Habib AG; He D
    Int J Infect Dis; 2022 Apr; 117():45-47. PubMed ID: 35108609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rubber plantation environment and Lassa fever epidemics in Liberia, 2008-2012: a spatial regression.
    Olugasa BO; Dogba JB; Ogunro B; Odigie EA; Nykoi J; Ojo JF; Taiwo O; Kamara A; Mulbah CK; Fasunla AJ
    Spat Spatiotemporal Epidemiol; 2014 Oct; 11():163-74. PubMed ID: 25457605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 52 Years of Lassa Fever Outbreaks in Nigeria, 1969-2020: An Epidemiologic Analysis of the Temporal and Spatial Trends.
    Agbonlahor DE; Akpede GO; Happi CT; Tomori O
    Am J Trop Med Hyg; 2021 Aug; 105(4):974-985. PubMed ID: 34460421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of antiviral therapeutics in animal models of Lassa fever.
    Warner BM; Siragam V; Stein DR
    Curr Opin Virol; 2019 Aug; 37():84-90. PubMed ID: 31357140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment.
    Wada YH; Ogunyinka IA; Yusuff KB; Ochu CL; Yahaya M; Khalid GM; Mutalub YB; Adeniye SB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010259. PubMed ID: 35286303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: implications for risk communication.
    Usuwa IS; Akpa CO; Umeokonkwo CD; Umoke M; Oguanuo CS; Olorukooba AA; Bamgboye E; Balogun MS
    BMC Public Health; 2020 Feb; 20(1):217. PubMed ID: 32050926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.